Gleiss Lutz advises ASML on the sale of Berliner Glas Medical and SwissOptic to JENOPTIK AG

​A team of Gleiss Lutz lawyers has advised the Dutch technology group ASML on the sale of 100 per cent of the shares in BG Medical Applications GmbH (“Berliner Glas Medical"), SwissOptic AG and the Chinese SwissOptic Co., Ltd. with registered office in Wuhan/China (together with SwissOptic AG, “SwissOptic") to JENOPTIK AG. Closing of the transaction is still subject to approval by the antitrust authorities and is planned for December 2021.

Berliner Glas Medical is a leading supplier of high-precision, custom optical components for the medical technology sector based in Berlin. SwissOptic is a specialist in the development and manufacture of optical components and assemblies, primarily for the medical technology, semiconductor and metrology industries. Together, the two companies employ around 500 people worldwide.

ASML is a leading supplier to the semiconductor industry. The company provides chipmakers with hardware, software and services to mass produce the patterns of integrated circuits (microchips). Together with its partners, ASML drives the advancement of more affordable, more powerful and more energy-efficient microchips. Headquartered in Veldhoven in the Netherlands, ASML is a multinational company traded on Euronext Amsterdam and NASDAQ, with offices in more than 60 cities across 16 countries. ASML has a workforce of more than 29,000.

Jenoptik with registered office in Jena, Germany is an international technology group active in the three photonics-based divisions Light & Optics, Light & Production and Light & Safety. Its key target markets primarily include the semiconductor, medical technology, automotive and mechanical engineering, traffic, aviation as well as security and defence technology industries. JENOPTIK AG is listed on the German Stock Exchange in Frankfurt and is included in the SDax and TecDax. With around 4,400 employees worldwide, Jenoptik generated revenue of approx. EUR 767 million in the 2020 financial year.

The following Gleiss Lutz team advised ASML on the transaction: Dr. Martin Viciano Gofferje (partner, lead), Dr. Johannes Weigel, Dr. Viktor Gorlow, Dr. Christoph Meissner (all Corporate/M&A, Berlin), Dr. Rut Steinhauser (partner), Josefine Chakrabarti, Anke Siemer-Arcq (all Berlin), Dr. Johanna Friedel (Stuttgart, all Employment), Dr. Alexander Molle (partner), Dr. Matthias Schilde (both IP/IT, Berlin), Dr. Stefan Mayer (partner), Dr. Ocka Stumm, Dr. Leonhard Kornwachs (all Tax), Dr. Alexander Fritzsche (partner), Dr. Saskia Kirchgeßner, Dr. Kristina Sirakova (all Competition/Antitrust, all Frankfurt), Dr. Enno Burk (counsel, Medical Law), Simon Wegmann (Data Protection, both Berlin), Dr. Jacob von Andreae (partner), Dr. Eva Koch (counsel), Aylin Hoffs, Matthias Hahn, Tatjana Schmidt, Lennart Förster (all Public Business Law, Düsseldorf), Konrad Discher (counsel, Real Estate), Marina Stoklasa (Compliance, both Frankfurt).

A Gleiss Lutz team led by Dr. Martin Viciano Gofferje already advised ASML last year on the acquisition of the Berliner Glas Group and in May this year on the sale of the technical glass division to Glas Trösch.